Resources

Optimizing IRT for Clinical Supply Management

WHITEPAPER: IRT systems can be a double-edged sword. Set up properly, it can make your clinical supply strategy a breeze to execute. Set up improperly, it can apply additional pressure and stress to a sponsor’s resupply execution

Water Cooler Chat: Clinical Trial Supplies in a Whole New World

AUDIO: 2020 has been a year that has delivered the world many challenges, the equilibrium has shifted and so many things are no longer as they should be. The Pharmaceutical Industry, like many others, has had to adjust to a “New Norm”

Water Cooler Chat Session: Australia: Bridge to Asia-Pacific Clinical Trials

AUDIO: Asia Pacific is a growing destination for conducting cost-effective clinical trials – between 2007 and 2018 trials in Asia constituted around 2

Water Cooler Chat: Australia: Bridge to Asia-Pacific Clinical Trials

AUDIO: Asia Pacific is a growing destination for conducting cost-effective clinical trials – between 2007 and 2018 trials in Asia constituted around 28.5% of all registered clinical trials globally

Water Cooler Chat: Running Clinical Trials in Israel & Growing Beyond

AUDIO: Commencing phase I trials in Israel can be started with short notice, as no licenses are needed. Phase II and III trials in Israel and globally require more planning and a longer timeline.

Water Cooler Chat: Handling IMP Returns and Destruction

AUDIO: With Direct-to-patient (DTP) protocols on the rise due to COVID, many sponsors are having to reconsider their returns & destruction strategy.

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Your bridge between life-changing therapies and patients